Abstract
Advanced breast cancers frequently metastasize to bone, resulting in osteolytic lesions, however, the underlying mechanisms are poorly understood. Runx2, a bone-specific transcriptional factor, is abnormally expressed in highly metastatic breast cancer cells. Here, we found that TSSC1 inhibits breast cancer cell invasion. Subsequently, TSSC1 is confirmed as a target of Runx2 and is negatively regulated by Runx2. Furthermore, overexpression of Runx2 induces bone osteolysis in a TSSC1-dependent manner. Our results may provide a strategy for the treatment of breast cancer and the prevention of skeletal metastasis.
Keywords:
Breast cancer; Osteolytic lesions; Runx2; TSSC1.
Copyright © 2013. Published by Elsevier Inc.
MeSH terms
-
Animals
-
Bone Neoplasms / genetics
-
Bone Neoplasms / metabolism
-
Bone Neoplasms / pathology
-
Bone Neoplasms / secondary*
-
Bone and Bones / metabolism
-
Bone and Bones / pathology*
-
Breast / metabolism
-
Breast / pathology
-
Breast Neoplasms / genetics
-
Breast Neoplasms / metabolism
-
Breast Neoplasms / pathology*
-
Cell Line, Tumor
-
Core Binding Factor Alpha 1 Subunit / genetics
-
Core Binding Factor Alpha 1 Subunit / metabolism*
-
Female
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Mice
-
Mice, SCID
-
Neoplasm Invasiveness / genetics
-
Neoplasm Invasiveness / pathology
-
Nuclear Proteins / genetics*
-
Nuclear Proteins / metabolism
-
Osteolysis*
-
Up-Regulation
Substances
-
Core Binding Factor Alpha 1 Subunit
-
EIPR1 protein, human
-
Nuclear Proteins
-
TSSC1 protein, mouse